[1]
Chao Yuan et al.trans. 2024. A real‑world pharmacovigilance study of FDA Adverse Event Reporting System (FAERS) events for Paxlovid and Molnupiravir. Human Biology. 94, 2 (Apr. 2024), 572–580.